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Laser-Induced Neocollagenesis in Focal Dermal Hypoplasia
Associated With Goltz Syndrome in a Girl
Andrew C. Krakowski, MD; David M. Ozog, MD; David Ginsberg, MD, MS; Carol Cheng, MD; Marsha L. Chaffins, MD

IMPORTANCE Current models of Goltz syndrome cannot estimate the overall neocollagenesis
and marked shift in collagen types after ablative fractional laser resurfacing (AFR) within
treated areas of focal dermal hypoplasia (FDH).
OBJECTIVES To clinically improve FDH by using AFR to characterize the specific ratio of
collagen types associated with observed clinical changes.
DESIGN, SETTING, AND PARTICIPANTS This case report of a girl with Goltz syndrome used
extensive laboratory evaluation and multiple observers blinded to the patient’s clinical status.
Serial samples of clinically unaffected skin constituted internal control specimens, with
clinical and histologic evaluations performed as part of a multicenter investigation. The
analysis tested the hypothesis that thermal microtrauma caused by AFR created a unique
environment that activated latent genes, inducing neocollagenesis and allowing the patient
to adaptively produce the collagen subtype that was specifically deficient at baseline.
INTERVENTIONS Two AFR treatments were administered within an area of FDH. Histologic

comparison of the pretreatment and posttreatment skin was performed using serial internal
controls.
MAIN OUTCOMES AND MEASURES Histologic changes, including Herovici collagen staining to
differentiate between types I and III collagen, within a treated area of mosaically affected
FDH compared with clinically unaffected skin.
RESULTS This female patient presented in the second decade of life with self-described red,
itchy skin within a large plaque of FDH on her left posterior thigh and calf. After AFR, skin
tightening and symptomatic relief were reported. Histologic findings demonstrated objective
thickening of the dermal collagen. A marked shift in collagen predominance from type III
(fetal/early wound) to type I (adult/mature) was observed.
CONCLUSIONS AND RELEVANCE Although further study is needed, this report shows
promising results and raises important questions about gene expression and the epigenetics
of Goltz syndrome–associated mutations and the local effects of AFR. Coupled with more
rigorous investigation, this novel technique may help reveal molecular workarounds
permitting innovative therapies that take advantage of the subtly different collagens that
exist within the skin.
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Laser-Induced Neocollagenesis in Goltz Syndrome

G

oltz syndrome is an X-linked dominant disorder most
commonly affecting the skin, eyes, teeth, and skeleton.1
The condition is caused by heterozygous and mosaic
PORCN (HGNC 17652) gene mutations located on Xp11.23.2,3
This region encodes an endoplasmic reticulum membrane protein involved in regulation of the Wnt signaling pathway, which
plays a crucial role in mesoderm and ectoderm development.4
Nearly 120 different mutations have been identified; however, owing to the overall complexity of the Wnt pathway and
the specific underlying pathophysiologic features of Goltz syndrome, neither severity nor presentation can be estimated
based on a specific mutation at this time.5-7 Dermatologic signs
are often present at birth and include aplasia cutis congenita,
telangiectasias, nodular fat herniations (ie, outpouchings), pigmentary alterations, dystrophic nails, thin and brittle hair, papillomas, and focal dermal hypoplasia (FDH) in a blaschkoid
distribution.1,8
Histologic evaluation of mosaically affected FDH demonstrates an atrophic dermis, increased dermal adipocytes, increased papillary dermal capillaries, abnormal fibroblasts, and
sparse, disorganized collagen.9-11 The mechanism by which the
excess fat enters the dermis remains controversial; theories include decreased collagen allowing for displacement of subdermal adipocytes into the dermis vs adipocyte overgrowth
within the dermis.
To our knowledge, no reports of spontaneous resolution
within mosaically affected skin have been published. Likewise, the specific ratio of collagen types within the abnormal network present in patients with Goltz syndrome has
yet to be characterized, and no attempts to improve FDH
directly through inducement of neocollagenesis have been
published.
Ablative fractional laser resurfacing (AFR) has been shown
to induce collagen remodeling in burn scars, chronic wounds,
and epidermolysis bullosa.12-15 We hypothesized that the local effects of AFR might induce neocollagenesis and help fortify the type III collagen present at baseline in the mosaically
affected areas of FDH despite the patient’s genetic predisposition to the contrary.

Methods
A female infant presented with erosion and fat herniation of
the left posterior leg, microphthalmia, ocular coloboma and
blindness of the left eye, lop ear deformity, left third and fourth
finger syndactyly, and left great toe polydactyly. She was subsequently diagnosed with Goltz syndrome by the late Robert
Goltz, MD. More than a decade later, she sought treatment for
self-described red, itchy skin within a large plaque of FDH on
her left posterior thigh and calf (Figure 1A). This area was cosmetically distressful and physically debilitating because the
loose skin was easily traumatized, irritated, and extremely pruritic. The possibility of AFR was introduced, and the family
elected to proceed with treatment. Informed parental consent and patient assent were obtained.
The patient underwent 2 sessions of fractional photothermolysis approximately 2 months apart using general anesthejamadermatology.com
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Key Points
Question How might ablative fractional laser resurfacing alter
local collagen composition within areas of focal dermal hypoplasia
associated with Goltz syndrome?
Findings In this case report of a patient with Goltz syndrome,
histologic changes demonstrated that, compared with internal
controls, mosaically affected areas of focal dermal hypoplasia
treated with ablative fractional laser resurfacing appear objectively
to thicken. A marked shift in collagen predominance from type III
(fetal/early wound) to type I (adult/mature) was found.
Meaning Thermal microtrauma caused by ablative fractional laser
resurfacing may create a unique environment that activates latent
genes, inducing neocollagenesis and allowing this patient with
Goltz syndrome to adaptively produce the collagen subtype that
was specifically deficient at baseline.

sia for pain management. Both treatments were performed
with an ablative microfractionated carbon dioxide laser
(Ultrapulse Deep FX; Lumenis, Ltd) at 35 mJ and 10% density
for the first treatment and at 20 mJ and 10% density for the
second treatment (Figure 1B); microspot size was fixed at approximately 0.12 mm. A petrolatum-based ointment was applied to the wound 3 times daily for 2 weeks. Biopsy specimens of mosaically affected skin and adjacent, unaffected skin
(ie, internal control specimens) were obtained before the initial AFR treatment and 8 weeks after the final treatment.

Results
Subjectively, the patient reported decreased pruritus and a
reduction in local trauma after AFR. Clinically, tightening
and thickening of her treated area were noticeable, with less
outpouching and skin laxity (Figure 1C-E). On histologic
analysis, both internal controls had findings consistent with
normal skin (Figure 2A and B). Before treatment, mosaically
affected skin revealed striking attenuation of dermal
collagen and loss of elastic tissue, consistent with FDH
(Figure 2C). After treatment, mosaically affected skin
revealed thickening and fibrosis of the dermal collagen,
increased vascularity, and no change in elastin (Figure 2D).
Herovici collagen staining of normal skin demonstrated a
predominance of type I collagen (Figure 3A). In contrast,
mosaically affected skin revealed a baseline predominance
of type III collagen before treatment (Figure 3B). After treatment, however, mosaically affected skin showed a marked
shift toward type I collagen (Figure 3C). The patient’s subjective improvement and observed clinical changes have
persisted more than 6 months postoperatively. We plan to
follow up with the patient in 1 year to assess whether
retreatment of the affected area is necessary.

Discussion
Ablative fractional laser resurfacing has been shown to induce neocollagenesis, leading to an increased ratio of type III
(Reprinted) JAMA Dermatology December 2017 Volume 153, Number 12
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Figure 1. Clinical Progression of Area of Focal Dermal Hypoplasia on Posterior Left Leg During Ablative Fractional Laser Resurfacing (AFR)
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A Pretreatment photograph

B

C

Posttreatment photograph 2 months after first AFR

D Posttreatment photograph 2 months after second AFR

E

Posttreatment photograph 5 months after second AFR

Intraoperative photograph during first AFR treatment

A, Pretreatment findings include mottling, fatty outpouchings, and overall laxity
of hypoplastic skin in mosaically affected areas. B, During the first AFR
treatment, sutures on the proximal posterior thigh denote biopsy sites for
pretreatment histologic evaluation of mosaically affected and unaffected skin.
The immediate, inflammatory effects of AFR treatment are noted, helping to
delineate areas of affected and unaffected skin. C, Two months after first AFR

treatment, clinical tightening of the skin and healing at both biopsy sites are
noted. D, Two months after the second AFR treatment, the locations of
posttreatment biopsies of mosaically affected and unaffected skin are indicated
with blue surgical marker. E, Five months after the second AFR treatment, skin
within treatment area appears tighter with less outpouchings and skin laxity.

to type I collagen. The mechanism underlying this process has
yet to be fully elucidated and involves the induction of growth
factors, including increasing transforming growth factor β3
expression, decreasing basic fibroblast growth factor expression, and increasing matrix metalloproteinase-1 expression
and involvement of microRNAs (especially miR-18a and
miR-19a).12,13
Management of FDH in Goltz syndrome poses a clinical
challenge because of the inability to correct or overcome the
underlying genetic mutation and elicit neocollagenesis. Histologic features of FDH demonstrate an atrophic dermis,
numerous subepidermal adipocytes, and a disorganized,
diminished collagen network.9,11 A potential explanation
for the defective collagen network based on studies of electron micrographs is that the affected fibroblasts are
dysfunctional.9 No published reports, to our knowledge,
have defined the specific ratios of type I to type III collagen
expression within areas of FDH in patients with Goltz syndrome. Our Herovici collagen stains revealed a baseline pre-

dominance of type III collagen that shifted markedly to a
type I predominance after AFR. This finding was unexpected for 2 reasons. First, patients with Goltz syndrome,
because of their underlying genetic mutation, do not show
spontaneous clinical improvement within areas of FDH after
normal macrotrauma. Second, AFR has been previously
associated with a shift toward type III collagen predominance in treatment of burn scars.13
These clinical and histologic observations could not
have been anticipated using current models of Goltz syndrome. We surmise that the thermal microtrauma caused by
AFR creates wounds from which the human body has yet to
evolve the means for healing normally. In this case, AFR
may have induced neocollagenesis through an alternative or
as yet unknown pathway, allowing the patient to adaptively
produce the type of collagen that was deficient at baseline,
effectively overcoming genetic programming in local areas
of FDH. This phenomenon, if true, may be analogous to the
use of hydroxyurea to increase the ratio of fetal hemoglobin
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Figure 2. Comparison of Histologic Images of Biopsy Specimens
A Pretreatment internal control

B

C

D Posttreatment mosaically affected skin

Pretreatment mosaically affected skin

Samples were obtained from the posterior left leg. Internal control specimens
consist of clinically unaffected adjacent serial skin samples. Normal histologic
features are apparent in internal controls. The mosaically affected skin sample
with focal dermal hypoplasia obtained before treatment with ablative fractional
laser resurfacing (AFR) demonstrates striking attenuation of the dermal
collagen (double-headed arrow in C), increased dermal adipocytes, and loss of

in patients with sickle cell anemia, with local effects of AFR
appearing to stimulate type I collagen production. The
patient’s unaffected, adjacent skin served as an internal
control throughout the treatment duration. Histologic findings also confirm that the tissue specimens were not
switched because the overall Goltz architecture was preserved through the mosaically affected stains albeit to a
lesser extent in the post-AFR specimens.

Limitations
This report is limited by the study of a single patient. The
field would benefit from rigorous long-term prospective
trials.
jamadermatology.com

Posttreatment internal control

elastic tissue characteristic of Goltz syndrome. The mosaically affected skin
sample obtained 2 months after final AFR treatment reveals thickening and
fibrosis of dermal collagen (double-headed arrow in D), increased vascularity,
and no change in elastin. All samples use hematoxylin-eosin staining (original
magnification ×100).

Conclusions
Although further study is needed to confirm the overall efficacy of an AFR protocol for the treatment of FDH plaques in
patients with Goltz syndrome, our report shows promising
results and raises important questions about gene expression and the epigenetics of Goltz syndrome–associated
mutations and the local effects of AFR. A dearth of treatment options exists for the cutaneous manifestations of
Goltz syndrome, and the skin defects may be distressing to
affected patients. In addition to the clinical benefits
afforded by AFR, this novel technique may help reveal
(Reprinted) JAMA Dermatology December 2017 Volume 153, Number 12
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Figure 3. Comparison of Types I and III Collagen
A Normal skin

C

B

Posttreatment mosaically affected skin

Histologic images were obtained from samples of the posterior leg. A, Internal
control specimen of skin predominantly contains type I collagen. B, Mosaically
affected skin sample obtained before ablative fractional laser resurfacing (AFR)
treatment demonstrates a predominance of type III collagen. C, Mosaically

affected skin sample obtained after AFR treatment reveals areas of fibrosis with
a marked shift to type I collagen. All samples use Herovici collagen staining, with
red indicating type I collagen and blue indicating type III collagen (original
magnification ×100).

molecular workarounds that permit innovative therapies to
take advantage of the subtly different collagens that exist
within the skin. Finally, this report suggests the potential to
use AFR for laser-assisted delivery of normal autologous

fibroblasts into the dermis through the microablated channels to help dilute the influence of mosaically affected fibroblasts, further bolstering the dermal network and helping to
clinically normalize areas of FDH.
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NOTABLE NOTES

Dermatology in Epic Poetry—From Beowulf to The Odyssey
Ajay Kailas, BS

Epic poems have captured the imaginations of readers, listeners, and artists alike for millennia. Michelangelo painted part of the Sistine Chapel
after being inspired by Dante’s Divine Comedy. Shakespeare’s 1602 play,
Troilus and Cressida, is based on The Iliad, an ancient Greek epic poem
attributed to Homer. All told, epic poems are captivating tales full of wonder and adventure. Particularly, they have often integrated dermatology in their unique plots. Beowulf is an Old English poem (written circa
AD 700-1000) that tells of the powerful Geat hero Beowulf, who visits
the mead hall, Heorot, to kill the evil monster Grendel. Grendel, bothered by the sounds of joy, has gruesomely slaughtered Heorot’s inhabitants for years. Owing to his magical gifts, no one has been able to slay
him. Grendel not only possesses incredible strength, but his skin is also
impenetrable to any blade: “Every nail, claw-scale, of that heathen
brute…was like barbed steel. To pierced him through, no time proofed
blade could cut his brutal, blood-caked claw.1” Beowulf notably does not
use a sword, but rather kills Grendel by directly ripping his arm off, causing him to bleed to death. In the 13th century German epic poem Das
Nibelungenlied (The Song of the Nibelungs), the skin of a main character is a weakness rather than a strength. In the beginning of the story,
the knight Siegfried is said to have slaughtered a dragon and bathed in
his blood—rendering him invulnerable to weaponry. However, a leaf from
a linden tree fell between his shoulders during this bath, leaving that area
untouched with blood. His wife, Kriemhild, mentions, “There one might
stab him, and thence is my care and dole,” indicating that this is his only
weakness (similar to Achilles’ heel).2 Unfortunately, Siegfried is later mur-
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dered by Hagen, who spears the unsuspecting knight while he is drinking from a brook. His death inspires Kriemhild’s revenge, which is the focus of the second half of Das Nibelungenlied. The Odyssey, a Greek epic
poem by Homer, details the legendary return of Odysseus to his home
of Ithaca after the Trojan war. Arriving after 20 years, he discovers that
multiple suitors are courting his wife, Penelope, presuming he is dead.
Odysseus is then transformed by Athena (the goddess of war) into an
old man as a disguise. However, his housekeeper, Eurycleia, identifies
him because of a hunting scar on his leg: “She immediately recognized
the scar; which once a boar inflicted upon him3.” This discovery demonstrates Eurycleia’s loyalty and allows the Odysseus and Penelope to
reunite. Together, they plot to kill the suitors and eventually restore peace
to Odysseus’ kingdom. Ultimately, epic poems are full of fantastic details and magical characters. Many tales involve the skin, demonstrating dermatology’s unique significance in literature. Hopefully, epic poetry will continue inspiring many more for ages to come.
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